Comparison of the efficacy of curcumin and its nano formulation on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in Wistar rats
Amany M Hamed, Dalia A Elbahy, Ahmed RH Ahmed, Shymaa A Thabet, Rasha Abdeen Refaei, Islam Ragab, Safaa Mohammed Elmahdy, Ahmed S Osman, Azza MA Abouelella · 2024
Read Comparison of the efficacy of curcumin and its nano formulation on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in Wistar rats by Amany M Hamed, Dalia A Elbahy, Ahmed RH Ahmed, Shymaa A Thabet, Rasha Abdeen Refaei, Islam Ragab, Safaa Mohammed Elmahdy, Ahmed S Osman, Azza MA Abouelella (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11696662.txt.
Description
Amany Hamed and co-authors compare in 2024 curcumin and its nano form in diabetic rats with liver fat and sugar faults. A steroid drug induced the diabetic state over two weeks in the model. Groups then got plain drug care, curcumin, or nano curcumin by mouth tube.
Both curcumin forms cut insulin resistance by about forty percent in treated rats. Fasting sugar fell by about a third or more in the same groups. Liver enzymes, blood fats, and a stress marker in liver and pancreas fell by thirty to fifty percent. Nano and plain forms both beat the untreated diabetic group across the board.
Catalog record
| CREATOR | Amany M Hamed, Dalia A Elbahy, Ahmed RH Ahmed, Shymaa A Thabet, Rasha Abdeen Refaei, Islam Ragab, Safaa Mohammed Elmahdy, Ahmed S Osman, Azza MA Abouelella |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |